Form 4 Filing for Alla Patlis - Common Stock Transaction

This filing details a transaction by Alla Patlis, Interim Chief Financial Officer & Controller of BRAINSTORM CELL THERAPEUTICS INC. On February 26, 2026, Patlis acquired 100,000 shares of Common Stock via restricted stock units (RSUs) awarded under the company's plan. These RSUs vest in two tranches: 50% upon grant and the remaining 50% six months later, contingent on continued employment. The reported shares were awarded at a price of $0.00 per share. Following this transaction, Patlis holds 144,349 shares. The RSUs vest as to 50% on the date of grant and the remaining 50% on the six-month anniversary of the grant date, provided employment continues.